Status: Not yet recruiting
Study of JMBI-001 in Patients With MYC-Positive Advanced Cancers
Evaluate the safety and tolerability of JMBI-001 in adults with MYC-positive advanced cancers.
Participants needed: 150
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Chengdu Anticancer Bioscience, Ltd.Updated: Oct 8, 2026
Eligibility criteria
Able to fully understand the study requirements, voluntarily agree to participat... [+8]
Difficulty swallowing or inability to swallow tablets. [+5]